New approaches to prevention of thrombosis in the antiphospholipid syndrome: Hopes, trials, and tribulations

This publication has 24 references indexed in Scilit:

• Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model
  Arthritis & Rheumatism, 2003
• Isoprenoids as mediators of the biological effects of statins
  Journal of Clinical Investigation, 2002
• Statins prevent endothelial cell activation induced by antiphospholipid (anti-?2-glycoprotein I) antibodies: Effect on the proadhesive and proinflammatory phenotype
  Arthritis & Rheumatism, 2001
• Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic Mice
  Stroke, 2000
• Involvement of Rho GTPases in the Transcriptional Inhibition of Preproendothelin-1 Gene Expression by Simvastatin in Vascular Endothelial Cells
  Circulation Research, 2000
• Increased Levels of Tissue Factor mRNA in Mononuclear Blood Cells of Patients with Primary Antiphospholipid Syndrome
  Thrombosis and Haemostasis, 1999
• 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Increase Fibrinolytic Activity in Rat Aortic Endothelial Cells
  Circulation Research, 1998
• Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
  Journal of Clinical Investigation, 1998
• Thrombosis in primary antiphospholipid syndrome. A pivotal role for monocyte tissue factor expression
  Arthritis & Rheumatism, 1997
• Activation of cultured vascular endothelial cells by antiphospholipid antibodies.
  Journal of Clinical Investigation, 1995